Cart summary

You have no items in your shopping cart.

Carboxyamidotriazole Orotate

SKU: orb1218562

Description

Carboxyamidotriazole Orotate is a cytostatic inhibitor of nonvoltage-operated calcium channels and calcium channel-mediated signaling pathways. Carboxyamidotriazole Orotate (L-651582 Orotate) is the orotate salt form of Carboxyamidotriazole (CAI), an orally bioavailable signal transduction inhibitor. Carboxyamidotriazole Orotate shows anti-tumor, anti-inflammatory and antiangiogenic effects.(In Vitro):Carboxyamidotriazole Orotate (0.1-10 μM; 24-96 hours) inhibits cell proliferation of LAMA84R and K562R cell lines.Carboxyamidotriazole Orotate inhibits the phosphorylation of a selected target of Bcr-Abl kinase. Tyrosine phosphorylation of CrkL is reduced by 5 μM Carboxyamidotriazole Orotate treatment.(In Vivo):Carboxyamidotriazole Orotate (342, 513 mg/kg; i.p.; Q1D×5 for two rounds) displays antitumor activity on CML xenografts.

Images & Validation

Key Properties

CAS Number187739-60-2
MW580.76
Purity>98% (HPLC)
FormulaC22H16Cl3N7O6
SMILESO=C(C(NC1=O)=CC(N1)=O)O.O=C(C2=C(N)N(CC3=CC(Cl)=C(C(C4=CC=C(Cl)C=C4)=O)C(Cl)=C3)N=N2)N
TargetCalcium Channel
SolubilityDMSO:5 mg/mL (8.61 mM; Need ultrasonic)

Bioactivity

In Vivo
Carboxyamidotriazole Orotate (342, 513 mg/kg; i.p.; Q1D×5 for two rounds) displays antitumor activity on CML xenografts. Animal model: Male NOD/SCID mice four-to-five week old. Dosage: 342, 513 mg/kg. Administration: i.p.; Q1D×5 for two rounds. Result: Increase survival.
In Vitro
Carboxyamidotriazole Orotate (0.1-10 μM; 24-96 hours) inhibits cell proliferation of LAMA84R and K562R cell lines. Carboxyamidotriazole Orotate inhibits the phosphorylation of a selected target of Bcr-Abl kinase. Tyrosine phosphorylation of CrkL is reduced by 5 μM Carboxyamidotriazole Orotate treatment. Cell Viability Assay Cell line: LAMA84R and K562R cell lines. Concentration: 0.1, 1, 5, 10 μM Incubation time: 24, 48, 72, 96 hours. Result: Showed a 50% growth reduction of the chronic myelogenous leukaemia (CML) lines with 5 μM CTO at 96 h time point. Western blot analysis. Cell line: LAMA84R and K562R cell lines. Concentration: 0.1, 1, 5 μM Incubation time: 72 and 96 hours. Result: A dose-dependent inhibition of both total and phosphorylated Bcr-Abl levels.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

L-651582 Orotate | CAI Orotate

Similar Products

  • Carboxyamidotriazole Orotate [orb1308493]

    99.88% (May vary between batches)

    187739-60-2

    580.76

    C22H16Cl3N7O6

    5 mg, 10 mg, 50 mg, 100 mg, 200 mg, 2 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Carboxyamidotriazole Orotate (orb1218562)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 240.00
10 mg
$ 350.00
25 mg
$ 610.00
50 mg
$ 890.00
100 mg
$ 1,250.00